Pathology and Diagnosis of Ovarian Cancer
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 124
Special Issue Editors
2. Oncological Surgery Research Group (OSRG), Department of Medicine, University Jaume I (UJI), 12004 Castellón, Spain
Interests: laparoscopic surgery; surgical oncology; gynecologic oncology; ovarian cancer; endometrial cancer
Interests: gynecologic oncology; ovarian cancer; surgical oncology; HPV; cervical cancer; endometrial cancer
Interests: gynecology; endometrial cancer; ovarian cancer, endometriosis and cervical pathology;
Special Issue Information
Dear Colleagues,
Ovarian cancer accounts for 5% of all cancers among women and causes more deaths than any other female genital tract cancer. Ovarian cancer is often diagnosed at an advanced stage, with about 70–80% of diagnoses occurring at an advanced stage; hence, for this group of patients, 5-year-survival is very low. Several prognostic factors for ovarian cancer have been studied and reported in an attempt to increase tumour-free survival, the most important and constant of these have been International Federation of Gynecology and Obstetrics (FIGO) stage, size of residual tumour after primary surgery and age at diagnosis. Other variables, such as time period, histological type and grade, performance status, preoperative CA 12.5 levels or other molecular markers appear to also be important.
In this forthcoming special Issue aim to learn about various essential aspects of the clinical and pathological diagnosis of ovarian malignant neoplasms.
Invited topics that are:
- Risk factors for ovarian cancer;
- Markers and new genes associated with ovarian cancer;
- Ovarian cancer subtypes and pathological classification;
- Identification of predictive and prognostics biomarkers;
- Predictors of treatment responses;
- Diagnostic tools;
- New advances in diagnostic techniques.
Prof. Dr. Antoni Llueca
Dr. Gemma Mancebo
Prof. Dr. Antonio Gil-Moreno
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ovarian cancer
- molecular markers
- diagnostic tools
- pathological classification
- prognosis
- treatment
